Ares Capital Corp
NASDAQ:ARCC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
19.8
22.18
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Ares Capital Corp
Wall Street
Price Targets
ARCC Price Targets Summary
Ares Capital Corp
According to Wall Street analysts, the average 1-year price target for
ARCC
is 23.1 USD
with a low forecast of 22.22 USD and a high forecast of 27.3 USD.
ARCC Last Price Targets
Ares Capital Corp
The latest public price target was made on Jul 30, 2024 by
Devin Ryan
from
JMP Securities
,
who expects
ARCC
stock to
rise by 3%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Devin Ryan
JMP Securities
|
22
USD
Upside 3% |
4 months ago
Jul 30, 2024
|
Ares Capital price target raised to $22 from $21 at JMP Securities
TheFly
|
Doug Harter
UBS
|
22
USD
Upside 3% |
5 months ago
Jul 18, 2024
|
Ares Capital price target raised to $22 from $21 at UBS
TheFly
|
Kanneth Lee
RBC Capital
|
22
USD
Upside 3% |
7 months ago
May 23, 2024
|
RBC Capital Reiterates Outperform Rating on Ares Capital (ARCC)
StreetInsider
|
Unknown Analyst
Citigroup
|
22
USD
Upside 3% |
1 year ago
Feb 8, 2023
|
Citigroup Maintains Buy on Ares Capital, Raises Price Target to $22
Benzinga
|
Unknown Analyst
J.P. Morgan
|
20.5
USD
Downside 4% |
1 year ago
Feb 8, 2023
|
JP Morgan Maintains Overweight on Ares Capital, Lowers Price Target to $20.5
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ARCC's stock price target?
Price Target
23.1
USD
According to Wall Street analysts, the average 1-year price target for
ARCC
is 23.1 USD
with a low forecast of 22.22 USD and a high forecast of 27.3 USD.
What is Ares Capital Corp's Revenue forecast?
Projected CAGR
6%
For the last 8 years the
compound annual growth rate for
Ares Capital Corp's revenue is
12%.
The projected
CAGR
for the next 3 years is
6%.
What is Ares Capital Corp's Operating Income forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Ares Capital Corp's operating income is
12%.
The projected
CAGR
for the next 3 years is
3%.
What is Ares Capital Corp's Net Income forecast?
Projected CAGR
-2%
For the last 8 years the
compound annual growth rate for
Ares Capital Corp's net income is
19%.
The projected
CAGR
for the next 3 years is
-2%.
You don't have any saved screeners yet
